"C.U.P. ORARI LUNEDì / VENERDì DALLE 8:00 18:00 SABATO DALLE 8:00 ALLE 12:00 TEL 0824 334026"

During the past decade, Azienda Ospedaliera G. Rummo conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera G. Rummo" #1 sponsor was "National Cancer Institute, Naples" with 13 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Consorzio Oncotech" with 2 trials sponsored, "Heart Care Foundation" with 2 trials sponsored and "Istituto Nazionale per lo Studio e la Cura dei Tumori" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera G. Rummo" #1 collaborator was "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials as a collaborator and "Mario Negri Institute for Pharmacological Research" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera G. Rummo" are "Breast Cancer" (5 trials), "Ovarian Cancer" (3 trials), "Heart Failure" (2 trials), "Lung Cancer" (2 trials) and "Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Azienda Ospedaliera G. Rummo" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera G. Rummo" are "Drug" (30 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Erlotinib" (3 trials), "Placebo" (3 trials), "cisplatin" (3 trials), "docetaxel" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera G. Rummo" are 25 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera G. Rummo". undefined are not yet recruiting, undefined are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Azienda Ospedaliera G. Rummo, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera G. Rummo, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Azienda Ospedaliera G. Rummo has several departments that took part in Clinical trials: "Azienda Ospedaliera G. Rummo - Cardiologia Interventistica E Utic" - 2 trials, "U.O. di Oncologia Medica Azienda Ospedaliera G Rummo" - 2 trials, "Azienda Ospedaliera Rummo; Divisione Di Reumatologia" - 2 trials